Found 85 matching trials
Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) PHASE1 This study is designed to provide pharmacokinetic data for the assessment o...
Show More Location
University Hospital Freiburg, Dep. for Child & Adolescent Psychiatry
Learn More & Join Trial
A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV PHASE3 This study is being done to see if a drug called long acting methylphenidat...
Show More Learn More & Join Trial
Evaluating Treatment of ADHD in Children With Down Syndrome PHASE4 Children with Down syndrome (DS) have a 3-5 time greater prevalence of Atte...
Show More Status
Active Not Recruiting
Location
University of California Davis MIND Institute
Learn More & Join Trial
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity PHASE3 Abuse of psychoactive substances is a behavior belonging to the field of ri...
Show More Learn More & Join Trial
The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD NA The aim of this study is comparing the effects of non-pharmacological inter...
Show More Location
Bambino Gesù Hospital and Research Institute
Learn More & Join Trial
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) PHASE3 This study evaluated the safety and clinical effect of treatment with methy...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Neurocognitive Effects of Extended-Release Methylphenidate in Healthy Adults EARLY_PHASE1 This study evaluated the effects of methylphenidate (MPH), a stimulant medi...
Show More Location
University of the Witwatersrand
Learn More & Join Trial
A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD PHASE4 This randomized, double-blind, flexible-dose, placebo-controlled, parallel ...
Show More Location
Center for Psychiatry and Behavioral Medicine Inc.
Learn More & Join Trial
Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. PHASE4 This study will evaluate the efficacy and safety of Dex-Methylphenidate Ext...
Show More Location
Clinical Study Center, LLC
Learn More & Join Trial
Methylphenidate in Myotonic Dystrophy Type 1 PHASE2 The purpose of this study is to determine whether methylphenidate is effect...
Show More Location
Institute of Readaptation in Physical Deficiency
Learn More & Join Trial